The Efficacy of VR and AR on Pruritus

Evaluation of the Efficacy of VR and AR on Pruritus Symptoms in Patients Receiving Hemodialysis Treatment

The research will be conducted randomly in order to determine the effect of VR and AR on pruritus symptom.

In this study, there will be three groups: intervention group 1 with autogenic relaxation (AR), intervention group 2 with virtual reality (VR) game application and control group with routine nursing care and kidney functions narration. The number of volunteers to be included in the study was determined by power analysis. Forty patients with itch symptoms will be included in each group. Preliminary application for all three groups will be performed in the patient group registered to the Dialysis Unit of the Nephrology Department of Hacettepe University and Baskent University Hospital. Socio-Demographic Form, 5-D Itch Scale, Dermatology Life Quality Index, State and Trait Anxiety Scale, Pruritus Behavior and SGO / OR Application Log.

Inclusion Criteria:

• Receiving hemodialysis treatment for the last 6 months,
• Receiving four hour hemodialysis treatment three times a week,
• 18-65 years of age,
• experiencing pruritus for the last month.
• Not taking any pharmacological / non-pharmacological treatment for pruritus
• No cognitive and psychiatric diagnosis,
• Do not use hearing aids,
• Open to communication and cooperation,
• Using smart mobile phone,
• Without liver disease and dermatological diseases,
• Patients who agree to participate in the study will be included in the study.

Exclusion Criteria:

• Pregnant in the research process,
• Kidney transplantation,
• Experiencing discomfort due to virtual reality glasses,
• Patients who voluntarily leave the trial will be excluded from the follow-up.